Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1090 (LINC01090) is a non-coding RNA locus that produces a transcript longer than 200 nucleotides, not translated into protein. As a member of the long intergenic non-coding RNA (lincRNA) family, LINC01090 likely acts in *trans* to regulate gene expression at the transcriptional or post-transcriptional level. Functional data specific to LINC01090 itself are limited, but lincRNAs in general play regulatory roles in cell biology and may act as molecular scaffolds or guides, influencing gene expression programs[3][5]. Recent studies have implicated LINC01090 as part of multi-cancer biomarker panels and as a prognostic indicator in lung adenocarcinoma, reflecting its expression correlation with clinical outcomes and the tumor immune microenvironment[2][4]. There is no direct evidence it serves as a traditional therapeutic target such as a receptor or enzyme, nor are there direct drug interactions reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1090 (LINC01090).